|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,800 GBX | +1.07% |
|
+4.11% | +24.09% |
| May. 08 | Gsk plc Announces Board Committee Changes | CI |
| May. 08 | GSK : Receives a Buy rating from Bernstein | ZD |
By Sabela Ojea
GlaxoSmithKline PLC said Tuesday that its drug Daprodustat has received marketing authorization by the European Medicines Agency.
The company said its application was accepted for review by the EMA.
The drug Daprodustat, aimed at treating anaemia of chronic kidney disease, is currently approved in Japan, the FTSE 100-listed company said.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
03-01-22 0227ET
| 1st Jan change | Capi. | |
|---|---|---|
| +24.09% | 90.86B | |
| +30.38% | 695B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 330B | |
| +3.73% | 283B | |
| +16.70% | 239B | |
| +8.78% | 204B | |
| -7.93% | 198B | |
| +7.68% | 168B |
GSK PLC 
